Drug-induced liver injury (DILI) is the single most common reason for regulatory actions concerning drugs, including failure to gain approval for marketing, removal from the market place and restriction of prescribing indications.
DILI is also a significant cause of morbidity and mortality in many patient populations. Due to its idiosyncratic nature, variable presentation and the vast number of potential causative drugs as well as herbal and dietary supplements, DILI is often diagnosed late in its course when patients have severe liver disease. DILI, including acute liver failure requiring liver transplantation, can happen anytime to anyone taking medications, even over the counter medications. Unfortunately, there are no tests to predict who is at risk nor to diagnose this problem. Read more
Before an audience of colleagues, family, and friends, four physicians received the 26th Annual Physician of the Year Award for providing excellence in patient care and fostering strong collaborative relationships with nurses. The physicians, nominated and selected by nurses and Nursing leadership, were honored through testimonials, photographs, and videos, which served as a display of collegial gratitude, during a ceremony held at Hatch Auditorium on Thursday, June 27.
The 2013 recipients were:
• Stelian Serban, MD, Assistant Professor of Anesthesiology, and Neurology, who received the Special Recognition Award;
• Leona Kim-Schluger, MD, Associate Director of the Recanati/Miller Transplantation Institute and Sydney J. Zweig Professor of Medicine, who received the Attending Award;
• Joanne Lai, MD, Fellow, Department of Pediatrics, who received the Fellow Award;
• Wamda Ahmed, MD, Neurology Chief Resident, who received the House Officer Award.
Significant advances in science are taking place, but translating them into clinical treatments for an array of human diseases is being hampered by public policies that are not aligned with the public good. That observation was articulated by Kenneth L. Davis, MD, President and Chief Executive Officer of The Mount Sinai Medical Center, during a discussion on “What’s Holding Back Medical Progress?,” one of three talks in which he participated at the ninth annual Aspen Ideas Festival, in Colorado, which ran from June 26 – July 2.
Mount Sinai’s Neuroscience Training Program offers predoctoral students an exciting and distinctive curriculum taught by a nationally and internationally recognized faculty, and a laboratory experience that builds on groundbreaking, cutting edge expertise in basic and translational neuroscience across a wide range of psychiatric and neurological disorders. A student’s training experience uniquely interfaces basic research within a clinical context by virtue of the close apposition of basic and clinical research and clinical treatment programs at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Hospital. Indeed, all graduate students take a class in clinical neuroscience where they meet patients with brain diseases.
Kravis Children’s Hospital at Mount Sinai is now ranked in 7 of the 10 specialties measured by U.S. News & World Report in its 2013-14 “Best Children’s Hospital” annual guidebook, moving up from six specialties last year. Significantly, Mount Sinai is also ranked as the No . 2 pediatric center in New York City, and is tied for No . 2 in the New York City metropolitan area out of the nine ranked children’s hospitals.
The seven specialties are: diabetes & endocrinology (No . 25), gastroenterology & GI surgery (No . 25),
nephrology (No . 26), urology (No . 28), pulmonology (No . 36), cancer (No . 46), and cardiology & heart surgery (No . 50). Read more
More than 1,100 interventional cardiac and vascular specialists participated in Mount Sinai Heart’s 16th Annual 2013 Live Symposium of Complex Coronary, Valvular, and Vascular Cases held from Tuesday, June 11, to Friday, June 14. It was the largest number of attendees in the event’s history and included cardiologists, vascular surgeons, radiologists, fellows, nurses, technicians, and other allied health care professionals from cardiac catheterization and vascular laboratories around the globe.
The four-day event featured 28 live broadcasts of cardiac procedures, as well as expert presentations and panel discussions on the latest advances and treatment approaches for complex coronary and cardiovascular disease. Read more
The Mount Sinai Medical Center recently celebrated the opening of the Steven and Alexandra Cohen Center for Labor and Birth, a state-of-the-art facility that will enable the Department of Obstetrics, Gynecology and Reproductive Science to accommodate its growing number of patients.
The 15,000-square-foot space, donated by the Steven A. and Alexandra M. Cohen Foundation, is located within the Jo Carole and Ronald S. Lauder Center for Maternity Care on the second floor of the Klingenstein Pavilion. The facility features a reception area, administrative offices, a private triage room, four private antepartum fetal surveillance rooms, three short-term triage bays, and 18 birthing rooms. Read more
Two legendary mentors at Icahn School of Medicine at Mount Sinai, Arthur H. Aufses Jr., MD, and Nathan Kase, MD, were honored in May by Mount Sinai’s Institute for Medical Education (IME) with Annual Excellence in Teaching Awards that bear their names.
Dr. Aufses and Dr. Kase were cited by IME’s leaders for their legacy to medical education. Dr. Aufses, Professor of Surgery, and Health, Evidence and Policy, retired as Chairman of the Department of Surgery in 1996. Dr. Kase, Dean Emeritus, and Professor of Obstetrics, Gynecology and Reproductive Science, and Medicine, served as Dean of the Medical School from 1985 through 1998.
Mount Sinai’s leadership in biomedical research and patient care, together with Rensselaer Polytechnic Institute’s expertise in engineering and invention prototyping, form the foundation for a new academic affiliation agreement between the two institutions. The agreement signals a new era of biomedical discovery and entrepreneurship for the Icahn School of Medicine at Mount Sinai and Rensselaer.
The partnership, commemorated at a signing ceremony on Wednesday, May 22, promotes collaboration in educational programs and research, with the ultimate goal of developing innovative diagnostic tools and treatments for patients around the world.